Legal Augmentation of Iodine Content in Table Salt from 10 to 20 mg KI/kg: Documented Effects a Decade Later

Abstract

In this brief review I have tried to gather all relevant data that have been published, concerning the long-term effects of the statutory requirement by Austrian authorities in 1990 to augment the iodine content of table salt from 10 mg KI/kg table salt to 20 mg KI/kg. Most of the available studies have a selection bias, studying persons referred to hospital for different reasons. Only studies on school children investigate more random samples of the population. However, in spite of the fact that iodine deficiency does not seem to be eradicated completely by this measure, some tendencies have become apparent.

The positive tendencies are: 1) thyroid volume in school children has shrunk in comparison to (historical) data before 1990 - leading to lack of goitre in this age group; 2) the expected rise in the incidence of thyrotoxicosis was only transient and not very pronounced - indeed thyrotoxicosis seems to have become rarer now than before; 3) the phenotype of thyroid cancer has changed towards the more benign variants.

Negative trends described since 1990 are 1) a small increase in the overall incidence of thyroid cancer (possibly due to better diagnostic tools), and 2) a relative rise of autoimmune thyroid disease.

All these tendencies await their substantiation by a nationwide survey that is based on strong epidemiological criteria.

Iodine prophylaxis - urinary iodine excretion - thyroid volume in school children - thyroid dysfunction - thyroid cancer

References

• 1 Bacher-Stier C, Riccabona G, Tötsch M, Kemmler G, Oberaigner W, Moncayo R. Incidence and clinical characteristics of thyroid carcinoma after iodine prophylaxis in an endemic goiter country.  Thyroid. 1997;  7 733-741
• 2 Braverman L E. Iodine induced thyroid disease.  Acta med Austriaca. 1990;  17 (Sonderheft 1) 29-32
• 3 Buchinger W, Lorenz-Wawschinek O, Semlitsch G, Langsteger W, Binter G, Bonelli R M, Eber O. Thyrotropin and thyroglobulin as an index of optimal iodine intake: Correlation with iodine excretion of 39 913 euthyroid patients.  Thyroid. 1997;  7 593-597
• 4 Burgess J R, Dwyer T, Mc Ardle K, Tucker P, Shugg D. The changing incidence and spectrum of thyroid carcinoma in Tasmania (1978 - 1998) during a transition from iodine sufficiency to iodine deficiency.  J Clin Endocrinol Metab. 2000;  85 1513-1517
• 5 Bürgi H, Kohler M, Morselli B. Thyrotoxicosis incidence in Switzerland and benefit of improved iodine supply.  Lancet. 1998;  352 1034
• 6 Delange F, Benker G, Caron Ph, Eber O, Ott W, Podoba J, Simescu M, Szybinsky Z, Vertongen F, Vitti P, Wiersinga W, Zamrazil V. Thyroid volume and urinary iodine in European schoolchildren: Standardization of values for assessment of iodine deficiency.  Eur J Endocrinol. 1997;  136 180-187
• 7 Delange F, Bürgi H. Iodine deficiency disorders in Europe.  WHO Bulletin. 1989;  67 317-325
• 8 Eber O. Zur Entwicklung der Jodsalzprophylaxe in Österreich.  Wien klin Wochenschr. 1998;  110 733-737
• 9 Franceschi S. Iodine intake and thyroid carcinoma - a potential risk factor.  Exp Clin Endocrinol Diabetes. 1998;  106 (Suppl 3) 38-44
• 10 Gallowitsch H J, Mikosch P, Kresnik E, Gomez I, Plöb J, Pipam W, Lind P. Schilddrüsenvolumina und Jodversorgung 6 - 17-jähriger Schüler. Ergebnisse 3 Jahre nach Erhöhung der Kochsalzjodierung.  Nucl Med. 1994;  33 235-238
• 11 Galvan G. Jodversorgung und Struma in Österreich.  Acta med Austriaca. 1993;  20 3-5
• 12 Galvan G. Iodmangel in den Alpenländern.  Med-Report (Blackwell Wissenschaft, Berlin). 2000;  24 2
• 13 ICCIDD statement, WHO statement. IDD Newsletter 1994 43
• 14 Krisch K, Depisch D, Jakesz R, Keminger K, Kokoschka R. Das papilläre Schilddrüsencarcinom.  Wien klin Wochenschr. 1980;  92 113-118
• 15 Laurberg P, Pedersen K M, Vestergaard H, Sigurdsson G. High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area vs. high incidence of Graves' disease in the young in a high iodine intake area: comparative surveys of thyrotoxicosis epidemiology in East-Jutland Denmark and Iceland.  J Internal Med. 1991;  229 415-420
• 16 Mostbeck A, Galvan G, Bauer P, Eber O, Atefie K, Dam K, Feichtinger H, Fritzsche H, Haydl H, Köhn H, König B, Koriska K, Kroiss A, Lind P, Markt B, Maschek W, Pesl H, Ramschak-Schwarzer S, Riccabona G, Stockhammer M, Zechmann W. The incidence of hyperthyroidism in Austria from 1987 to 1995 before and after an increase in salt iodization in 1990.  Eur J Nucl Med. 1998;  25 367-374
• 17 Österreichisches Krebsregister. 3. 2. 3. : Krebsinzidenz. Langgassner J for the Österreichisches Statistisches Zentralamt. Medizinische Dokumentation. Wien; Österreichischer Bundesverlag 1998
• 18 Rybakov S J, Komissarenko I V, Tronko N D, Kvachenyuk A N, Bogdanova T I, Kovalenko A E, Bolgov M Y. Thyroid cancer in children of Ukraine after the Chernobyl accident.  World J Surg. 2000;  24 1446-1449
• 19 Todd C H, Allain T, Gomo Z AR, Hasler J A, Ndiweni M, Oken E. Increase in thyrotoxicosis associated with iodine supplementats in Zimbabwe.  Lancet. 1995;  346 1563-1564
• 20 Wagner B, Karup S B, Raber W, Schneider B, Nowotny P, Waldhäusl W, Bratusch-Marrain P, Vierhapper H. Jodprophylaxe und Jodausscheidung in den Regionen Wien und Waldviertel.  Wien klin Wochenschr. 1998;  110 751-754
• 21 Weissel M, Bergmann H, Steidler B. Struma maligna. Retrospektive Analyse des Patientengutes und der Behandlungsergebnisse der Nuklearmedizinischen Abteilung der II. Medizinischen Universitätsklinik Wien von 1973 - 1982.  Acta med Austriaca. 1983;  10 83-91
• 22 Williams E D, Doniach I, Bjarnason O, Michie W. Thyroid cancer in an iodine rich area: A histopathological study.  Cancer. 1977;  39 215-222
• 23 Yang F, Teng W, Shan Z, Guan H, Li Y, Jin Y, Hu F, Shi X, Tong Y, Chen W, Yuan B, Wang Z, Cui B, Yang S. Epidemiological survey on the relationship between different iodine intakes and the prevalence of hyperthyroidisim.  Europ J Endocrinol. 2002;  146 613-618